MBX Biosciences, Inc. Common Stock (MBX) — Financial Flexibility Index
MBX Biosciences, Inc. Common Stock (MBX) has a Financial Flexibility Index of -1.32x as of March 2026. Free cash flow of $-19.77 Million (operating CF $-20.21 Million minus capex $437.00K) represents -1% of total liabilities ($14.95 Million). Also explore MBX Biosciences, Inc. Common Stock equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
MBX Biosciences, Inc. Common Stock Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for MBX Biosciences, Inc. Common Stock across 4 annual periods. Check MBX Biosciences, Inc. Common Stock asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for MBX Biosciences, Inc. Common Stock (2022–2025)
Year-by-year free cash flow to debt coverage for MBX Biosciences, Inc. Common Stock. For the full company profile including market capitalisation, see market value of MBX Biosciences, Inc. Common Stock.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.90x | $-78.02 Million | $-79.95 Million | $15.92 Million | ▼ -1.0% |
| 2024 | -4.85x | $-53.81 Million | $-54.68 Million | $11.09 Million | ▼ -2285.7% |
| 2023 | -0.20x | $-31.85 Million | $-31.98 Million | $156.65 Million | ▲ +21.4% |
| 2022 | -0.26x | $-22.68 Million | $-23.12 Million | $87.70 Million | — |